sur Wellgistics Health, Inc. (NASDAQ:WGRX)
Wellgistics Health Expands Platform with New Partnerships and Products
Wellgistics Health, Inc. (NASDAQ:WGRX) has reported a strong Q2 2025. The company added 116 new pharmaceutical manufacturer partnerships, introduced over 12,400 new products, and welcomed 275+ pharmacies to its platform. This growth reflects their commitment to creating a modern drug ecosystem aimed at connecting manufacturers directly to pharmacies, providers, employers, and patients.
The company's CEO, Brian Norton, highlighted the ongoing structural transformation. Wellgistics is focused on delivering speed and visibility to its partners. The expanded network aims to facilitate real-time, patient-focused drug access on a national scale.
The Wellgistics platform manages the entire prescription journey, with a focus on advancing direct-to-patient care programs. This includes wholesale distribution, digital Rx routing, and various hub services designed to streamline prescription fulfillment.
R. H.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Wellgistics Health, Inc.